DK0874830T3 - Metalloproteinaseinhibitor, farmaceutisk præparat indeholdende denne og den farmaceutiske anvendelse samt en fremgangsmåde til fremstilling deraf - Google Patents

Metalloproteinaseinhibitor, farmaceutisk præparat indeholdende denne og den farmaceutiske anvendelse samt en fremgangsmåde til fremstilling deraf

Info

Publication number: DK0874830T3
Authority: DK; Denmark
Prior art keywords: pharmaceutical; preparation; metalloproteinase inhibitor; preparation containing; pharmaceutical use
Prior art date: 1995-12-08

Application number

DK96944229T

Other languages

Danish (da)

English (en)

Inventor

Scott E Zook

Raymond Dagnino Jr

Michael E Deason

Steven L Bender

Michael J Melnick

Original Assignee

Agouron Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-12-08

Filing date

1996-12-05

Publication date

2003-04-22

1996-12-05 Application filed by Agouron Pharma filed Critical Agouron Pharma

2003-04-22 Application granted granted Critical

2003-04-22 Publication of DK0874830T3 publication Critical patent/DK0874830T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/04—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/12—1,4-Thiazines; Hydrogenated 1,4-thiazines not condensed with other rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Rheumatology (AREA)
Oncology (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Pyridine Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

DK96944229T 1995-12-08 1996-12-05 Metalloproteinaseinhibitor, farmaceutisk præparat indeholdende denne og den farmaceutiske anvendelse samt en fremgangsmåde til fremstilling deraf DK0874830T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US56976695A	1995-12-08	1995-12-08
PCT/US1996/019328 WO1997020824A1 (en)	1995-12-08	1996-12-05	Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation

Publications (1)

Publication Number	Publication Date
DK0874830T3 true DK0874830T3 (da)	2003-04-22

Family

ID=24276764

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK96944229T DK0874830T3 (da)	1995-12-08	1996-12-05	Metalloproteinaseinhibitor, farmaceutisk præparat indeholdende denne og den farmaceutiske anvendelse samt en fremgangsmåde til fremstilling deraf

Country Status (39)

Country	Link
US (1)	US6153757A (es)
EP (2)	EP0874830B1 (es)
JP (1)	JP2000502330A (es)
KR (1)	KR19990072009A (es)
CN (2)	CN1542002A (es)
AP (2)	AP1368A (es)
AT (2)	ATE283264T1 (es)
AU (1)	AU725831C (es)
BG (1)	BG64279B1 (es)
BR (1)	BR9611929A (es)
CA (1)	CA2238306A1 (es)
CO (1)	CO4790150A1 (es)
CZ (1)	CZ292942B6 (es)
DE (2)	DE69626684T2 (es)
DK (1)	DK0874830T3 (es)
EA (1)	EA003294B1 (es)
ES (2)	ES2195034T3 (es)
GE (1)	GEP20012388B (es)
GT (2)	GT199700015A (es)
HR (1)	HRP970031A2 (es)
HU (1)	HUP9902092A3 (es)
ID (1)	ID17624A (es)
IL (6)	IL124559A (es)
MX (1)	MX9804457A (es)
MY (1)	MY117290A (es)
NO (1)	NO311360B1 (es)
NZ (1)	NZ325559A (es)
OA (1)	OA10794A (es)
PA (1)	PA8431301A1 (es)
PE (1)	PE69298A1 (es)
PL (1)	PL327275A1 (es)
PT (1)	PT874830E (es)
SI (1)	SI0874830T1 (es)
SK (1)	SK73898A3 (es)
SV (1)	SV1997000008A (es)
TR (1)	TR199800990T2 (es)
TW (1)	TW546293B (es)
WO (1)	WO1997020824A1 (es)
YU (1)	YU21597A (es)

Families Citing this family (114)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6500948B1 (en)	1995-12-08	2002-12-31	Agouron Pharmaceuticals, Inc.	Metalloproteinase inhibitors-compositions, uses preparation and intermediates thereof
IL124559A (en) *	1995-12-08	2004-07-25	Agouron Pharma	Inhibitors of metalloproteinases, pharmaceutical preparations containing them and their use
PT939628E (pt) *	1996-07-22	2003-07-31	Monsanto Co	Inibidores tiolsulfona de metaloproteases
US6747027B1 (en)	1996-07-22	2004-06-08	Pharmacia Corporation	Thiol sulfonamide metalloprotease inhibitors
BR9712792A (pt) *	1996-08-28	1999-12-14	Procter & Gamble	Inibidores de metaloprotease bidentada.
WO1998008822A1 (en) *	1996-08-28	1998-03-05	The Procter & Gamble Company	1,3-diheterocyclic metalloprotease inhibitors
NZ334256A (en)	1996-08-28	2000-11-24	Procter & Gamble	1-substituted sulphonyl-pyrrolidine derivatives useful as metalloprotease inhibitors
EP0923561B1 (en) *	1996-08-28	2002-10-23	The Procter & Gamble Company	Heterocyclic metalloprotease inhibitors
US6872742B2 (en)	1996-08-28	2005-03-29	The Procter & Gamble Company	Substituted cyclic amine metalloprotease inhibitors
CN1228773A (zh) *	1996-08-28	1999-09-15	普罗克特和甘保尔公司	杂环金属蛋白酶抑制剂
US6548524B2 (en)	1996-10-16	2003-04-15	American Cyanamid Company	Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors
US6228869B1 (en)	1996-10-16	2001-05-08	American Cyanamid Company	Ortho-sulfonamido bicyclic hydroxamic acids as matrix metalloproteinase and TACE inhibitors
US5929097A (en) *	1996-10-16	1999-07-27	American Cyanamid Company	Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
US5977408A (en) *	1996-10-16	1999-11-02	American Cyanamid Company	Preparation and use of β-sulfonamido hydroxamic acids as matrix metalloproteinase and TACE inhibitors
US5962481A (en)	1996-10-16	1999-10-05	American Cyanamid Company	Preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
DE69718038D1 (de) *	1996-10-16	2003-01-30	American Cyanamid Co	Herstellung und verwendung von ortho-sulfonamido-heteroarylhydroxamsäuren als matrix-metalloproteinase und tace inhibitoren
US6008243A (en) *	1996-10-24	1999-12-28	Agouron Pharmaceuticals, Inc.	Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use
US6174915B1 (en)	1997-03-25	2001-01-16	Agouron Pharmaceuticals, Inc.	Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
JP2001506257A (ja)	1996-12-17	2001-05-15	藤沢薬品工業株式会社	Ｍｍｐまたはｔｎｆ阻害剤としてのピペラジン化合物
WO1998039326A1 (en)	1997-03-04	1998-09-11	Monsanto Company	Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
US6638952B1 (en)	1997-03-04	2003-10-28	Pharmacia Corporation	Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds
US6476027B1 (en)	1997-03-04	2002-11-05	Monsanto Company	N-hydroxy 4-sulfonyl butanamide compounds
US6794511B2 (en)	1997-03-04	2004-09-21	G. D. Searle	Sulfonyl aryl or heteroaryl hydroxamic acid compounds
US6696449B2 (en)	1997-03-04	2004-02-24	Pharmacia Corporation	Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors
US7115632B1 (en)	1999-05-12	2006-10-03	G. D. Searle & Co.	Sulfonyl aryl or heteroaryl hydroxamic acid compounds
DE69828783T2 (de) *	1997-03-04	2006-01-12	Pharmacia Corp.	Hydroxamsäure-sulfonamid-derivate mit amidiertem aromatischen ring
US6087359A (en) *	1997-03-04	2000-07-11	Getman; Daniel P.	Thioaryl sulfonamide hydroxamic acid compounds
WO1998038859A1 (en)	1997-03-04	1998-09-11	Monsanto Company	Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
US5985900A (en) *	1997-04-01	1999-11-16	Agouron Pharmaceuticals, Inc.	Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
EP0973748A1 (en) *	1997-04-01	2000-01-26	Agouron Pharmaceuticals, Inc.	Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
AU7294098A (en) *	1997-05-09	1998-11-27	Agouron Pharmaceuticals, Inc.	Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
JP2004137284A (ja) *	1997-06-17	2004-05-13	Kaken Pharmaceut Co Ltd	２−スルファモイル安息香酸誘導体
KR100352316B1 (ko)	1997-07-31	2002-09-12	더 프록터 앤드 갬블 캄파니	메탈로프로테아제억제제로서사용되는술포닐아미노치환히드록삼산유도체
US6403632B1 (en) *	2000-03-01	2002-06-11	Bristol Myers Squibb Pharma Co	Lactam metalloprotease inhibitors
JPH11199512A (ja) *	1997-10-24	1999-07-27	Pfizer Prod Inc	変形性関節症および他のｍｍｐ媒介疾患の治療のためのｍｍｐ−１３選択的阻害剤の使用
CN1279669A (zh)	1997-11-14	2001-01-10	G·D·瑟尔公司	芳族砜异羟肟酸金属蛋白酶抑制剂
US6750228B1 (en)	1997-11-14	2004-06-15	Pharmacia Corporation	Aromatic sulfone hydroxamic acid metalloprotease inhibitor
US20010039287A1 (en)	1997-11-14	2001-11-08	Thomas E Barta	Aromatic sulfone hydroxamic acid metalloprotease inhibitor
US6071903A (en) *	1998-01-27	2000-06-06	American Cyanamid Company	2,3,4,5-tetrahydro-1H-[1,4]-benzodiazepine-3-hydroxyamic acids
JP2002501056A (ja) *	1998-01-27	2002-01-15	アメリカン・サイアナミド・カンパニー	マトリクス金属プロテイナーゼ阻害薬としての２，３，４，５−テトラヒドロ−１ｈ−［１，４］−ベンゾジアゼピン−３−ヒドロキサム酸
US6410580B1 (en)	1998-02-04	2002-06-25	Novartis Ag	Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
IL137465A0 (en)	1998-02-04	2001-07-24	Novartis Ag	Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
US6329418B1 (en)	1998-04-14	2001-12-11	The Procter & Gamble Company	Substituted pyrrolidine hydroxamate metalloprotease inhibitors
EP1077978A1 (en)	1998-05-14	2001-02-28	Du Pont Pharmaceuticals Company	Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
AU4692399A (en)	1998-06-17	2000-01-05	Du Pont Pharmaceuticals Company	Cyclic hydroxamic acids as metalloproteinase inhibitors
DK1357109T3 (da)	1998-06-18	2008-09-08	Hoffmann La Roche	Fremgangsmåde til arylalkylsulfid
FR2780402B1 (fr) *	1998-06-30	2001-04-27	Adir	Nouveaux composes acides carboxyliques et hydroxamiques inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE69925840T2 (de) *	1998-08-12	2006-05-04	Pfizer Products Inc., Groton	Tace inhibitoren
UA59453C2 (uk) *	1998-08-12	2003-09-15	Пфайзер Продактс Інк.	Похідні гідроксипіпеколат гідроксамової кислоти як інгібітори матричних металопротеїназ
US6509337B1 (en) *	1998-09-17	2003-01-21	Pfizer Inc.	Arylsulfonyl Hydroxamic Acid derivatives as MMP and TNF inhibitors
JP2002525305A (ja) *	1998-09-30	2002-08-13	ザ、プロクター、エンド、ギャンブル、カンパニー	スルホンアミドを用いた脱毛治療の方法
US6300341B1 (en)	1998-09-30	2001-10-09	The Procter & Gamble Co.	2-substituted heterocyclic sulfonamides
US6307049B1 (en)	1998-09-30	2001-10-23	The Procter & Gamble Co.	Heterocyclic 2-substituted ketoamides
US6288261B1 (en) *	1998-12-18	2001-09-11	Abbott Laboratories	Inhibitors of matrix metalloproteinases
CN1371286A (zh) *	1998-12-23	2002-09-25	G.D.西尔公司	环氧激酶－2抑制剂和基质金属蛋白酶抑制剂联合应用治疗瘤形成疾病的方法
US6858598B1 (en) *	1998-12-23	2005-02-22	G. D. Searle & Co.	Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6313123B1 (en)	1999-01-27	2001-11-06	American Cyanamid Company	Acetylenic sulfonamide thiol tace inhibitors
US6762178B2 (en)	1999-01-27	2004-07-13	Wyeth Holdings Corporation	Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
AR022423A1 (es) *	1999-01-27	2002-09-04	American Cyanamid Co	Compuestos derivados de acidos 2,3,4,5-tetrahidro-1h-[1,4]benzodiazepina-3-hidroxamicos, composicion farmaceutica que los comprenden, y el uso de losmismos para la manufactura de un medicamento
US6200996B1 (en)	1999-01-27	2001-03-13	American Cyanamid Company	Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
US6340691B1 (en)	1999-01-27	2002-01-22	American Cyanamid Company	Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitors
US6544984B1 (en)	1999-01-27	2003-04-08	American Cyanamid Company	2,3,4,5-tetrahydro-1H-(1,4)benzodiazepine-3-hydroxamic acids
CN1178915C (zh)	1999-01-27	2004-12-08	惠氏控股有限公司	含有炔基的异羟肟酸衍生物、其制备及其作为基质金属蛋白酶抑制剂/TNF-α转变酶抑制剂的用途
US6326516B1 (en)	1999-01-27	2001-12-04	American Cyanamid Company	Acetylenic β-sulfonamido and phosphinic acid amide hydroxamic acid TACE inhibitors
US6753337B2 (en)	1999-01-27	2004-06-22	Wyeth Holdings Corporation	Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitors
US6277885B1 (en)	1999-01-27	2001-08-21	American Cyanamid Company	Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
US6946473B2 (en)	1999-01-27	2005-09-20	Wyeth Holdings Corporation	Preparation and use of acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors
US6225311B1 (en)	1999-01-27	2001-05-01	American Cyanamid Company	Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors
YU57101A (sh)	1999-02-08	2005-06-10	G.D. Saerle & Co.	Sulfamat hidroksamična kiselina inhibitor metaloproteaze
US6800646B1 (en)	1999-02-08	2004-10-05	Pharmacia Corporation	Sulfamato hydroxamic acid metalloprotease inhibitor
PL350452A1 (en)	1999-03-03	2002-12-16	Procter & Gamble	Dihetero-substituted metalloprotease inhibitors
EP1165501A1 (en)	1999-03-03	2002-01-02	The Procter & Gamble Company	Alkenyl- and alkynyl-containing metalloprotease inhibitors
AUPP982399A0 (en) *	1999-04-19	1999-05-13	Fujisawa Pharmaceutical Co., Ltd.	Mmp inhibitor
US6583299B1 (en)	1999-05-20	2003-06-24	G.D. Searle & Co.	α-amino-β-sulfonyl hydroxamic acid compounds
US6869951B1 (en)	1999-07-16	2005-03-22	Pharmacia Corporation	Method of changing conformation of a matrix metalloproteinase
CO5210860A1 (es)	1999-10-01	2002-10-30	Hoffmann La Roche	Nuevos derivados de pirimidina-2,4,6-triona
BR0109469A (pt) *	2000-03-17	2003-04-29	Bristol Myers Squibb Co	Compostos derivados de b-aminoácidos, composição farmacêutica, método para o tratamento ou prevenção de disfunções inflamatórias, método para o tratamento de condições ou doenças mediadas por mmps, tnf, aggrecanase ou uma combinação destes em mamìferos e uso do composto
IL151552A0 (en)	2000-03-17	2003-04-10	Bristol Myers Squibb Pharma Co	Cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
EP1138680A1 (en) *	2000-03-29	2001-10-04	Pfizer Products Inc.	Gem substituted sulfonyl hydroxamic acids as MMP inhibitors
US6548667B2 (en) *	2000-04-07	2003-04-15	Samsung Electronics Co. Ltd.	Sulfonamide derivative as a matrix metalloproteinase inhibitor
US6683093B2 (en)	2000-05-12	2004-01-27	Pharmacia Corporation	Aromatic sulfone hydroxamic acids and their use as protease inhibitors
US6927216B2 (en)	2000-10-03	2005-08-09	Bristol-Myers Squibb Pharma Company	Cyclic sulfonyl compounds as inhibitors of metalloproteases
EP1355901A2 (en)	2001-01-11	2003-10-29	Bristol-Myers Squibb Pharma Company	1,1-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLOPROTEASE AND TNF-$g(a)
US6642255B2 (en)	2001-01-11	2003-11-04	Bristol-Myers Squibb Pharma Company	1,2,-Disubstituted cyclic inhibitors of matrix metalloproteases and TNF-alpha
FR2819252A1 (fr) *	2001-01-11	2002-07-12	Servier Lab	Nouveaux derives d'acide hydroxamique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MXPA01013326A (es)	2001-02-14	2002-08-26	Warner Lambert Co	Bifenil sulfonamidas utiles como inhibisdores de metaloproteinasa de matriz.
CA2439539A1 (en)	2001-03-15	2002-09-26	Matthew E. Voss	Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteinases and tnf-alpha converting enzyme (tage)
US6716845B2 (en)	2001-03-30	2004-04-06	Hoffmann-La Roche Inc.	Barbituric acid derivatives
BR0209525A (pt)	2001-05-11	2004-03-09	Pharmacia Corp	Hidroxamatos de sulfona aromáticos e uso dos mesmos como inibidores de protease
WO2002096420A2 (en) *	2001-05-29	2002-12-05	Guilford Pharmaceuticals Inc.	Method for treating nerve injury caused by surgery
US6683078B2 (en)	2001-07-19	2004-01-27	Pharmacia Corporation	Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors
AUPR726201A0 (en) *	2001-08-24	2001-09-20	Fujisawa Pharmaceutical Co., Ltd.	New use of a cyclic compound
JP2003081937A (ja) *	2001-09-07	2003-03-19	Bayer Ag	ベンゼンスルホンアミド誘導体
CN1610661A (zh)	2001-11-01	2005-04-27	惠氏控股公司	用作基质金属蛋白酶和tace的抑制剂的丙二烯芳基磺酰胺异羟肟酸
AU2002356979A1 (en) *	2001-11-30	2003-06-17	Bristol-Myers Squibb Company	Method of producing n-((2s)-sulfanyl-4-(1,5,5-trimethylhydantoinyl)butanoyl)-l-leucyl-l-tert-leucine n-methylamide and intermediate thereof
PE20030701A1 (es) *	2001-12-20	2003-08-21	Schering Corp	Compuestos para el tratamiento de trastornos inflamatorios
WO2003091247A2 (en)	2002-04-25	2003-11-06	Pharmacia Corporation	Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
WO2003104224A1 (en)	2002-06-10	2003-12-18	Pfizer Inc.	Metabolites of prinomastat and their sythesis
US7629341B2 (en) *	2002-06-12	2009-12-08	Symphony Evolution, Inc.	Human ADAM-10 inhibitors
CA2490646A1 (en) *	2002-06-25	2003-12-31	Pharmacia Corporation	Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors
AU2003304456A1 (en)	2002-12-23	2005-03-16	Wyeth Holdings Corporation	Acetylenic aryl sulfonate hydroxamic acid tace and matrix metalloproteinase inhibitors
CA2513716A1 (en) *	2003-02-14	2004-08-26	Applied Research Systems Ars Holding N.V.	Piperazine-2-carboxamide derivatives
JP2006517960A (ja) *	2003-02-18	2006-08-03	ファイザーインコーポレイテッド	Ｃ型肝炎ウイルスの阻害剤、それを使用する組成物および治療法
RU2380356C2 (ru)	2003-03-24	2010-01-27	Актимис Фармасьютикалз, Инк.	Производные 2-фенокси и 2-фенилсульфонамида с ссr3 антагонистической активностью для лечения астмы и других воспалительных или иммунологических заболеваний
GT200500139A (es) *	2004-06-08	2005-07-25		Metodo para la preparacion de acidos hidroxamicos
EP2041181B1 (en) *	2006-06-08	2011-05-18	Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)	Specific protease inhibitors and their use in cancer therapy
WO2009052200A2 (en) *	2007-10-16	2009-04-23	Symphony Evolution, Inc.	Human adam-10 inhibitors
EP2147684A1 (en) *	2008-07-22	2010-01-27	Bracco Imaging S.p.A	Diagnostic Agents Selective Against Metalloproteases
WO2011081884A1 (en)	2009-12-14	2011-07-07	Massachusetts Institute Of Technology	Systems and methods related to optical nanosensors including photoluminescent nanostructures
IT1401253B1 (it)	2010-04-23	2013-07-18	Uni Degli Studi Carlo Bo Urbino	Uso del sulodexide per la riduzione delle metalloproteinasi di matrice.
EP2763972A1 (en) *	2011-10-04	2014-08-13	Institut National de la Sante et de la Recherche Medicale (INSERM)	New apoptosis inducing compounds
CA3115038A1 (en)	2018-10-04	2020-04-09	Inserm (Institut National De La Sante Et De La Recherche Medicale)	Egfr inhibitors for treating keratodermas
WO2020218316A1 (ja) *	2019-04-26	2020-10-29	日産化学株式会社	アリールスルホン酸エステル化合物の製造方法
US20220227792A1 (en) *	2019-06-14	2022-07-21	Loyola University Of Chicago	Carborane hydroxamic acid matrix metalloproteinase agents for boron neutron capture therapy

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4032639A (en) *	1976-03-22	1977-06-28	American Home Products Corporation	2,3,4,4A-Tetrahydro-1H-pyrazino[1,2-a,]quinoxalin-5(6H)-ones and derivatives thereof for relieving hypertension
ZW23187A1 (en) *	1986-12-15	1988-06-29	Hoffmann La Roche	Phosphinic acid derivatives
GB9000846D0 (en) *	1990-01-15	1990-03-14	Beecham Group Plc	Novel compounds
GB9022117D0 (en) *	1990-10-11	1990-11-21	Beecham Group Plc	Novel compounds
US5183900A (en) *	1990-11-21	1993-02-02	Galardy Richard E	Matrix metalloprotease inhibitors
US5189178A (en) *	1990-11-21	1993-02-23	Galardy Richard E	Matrix metalloprotease inhibitors
US5239078A (en) *	1990-11-21	1993-08-24	Glycomed Incorporated	Matrix metalloprotease inhibitors
WO1992009565A1 (en) *	1990-12-03	1992-06-11	Celltech Limited	Peptidyl derivatives
CA2102890A1 (en) *	1991-05-28	1992-11-29	Soumya P. Sahoo	Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative active agents
US5256657A (en) *	1991-08-19	1993-10-26	Sterling Winthrop, Inc.	Succinamide derivative matrix-metalloprotease inhibitors
GB9211706D0 (en) *	1992-06-03	1992-07-15	Celltech Ltd	Peptidyl derivatives
GB9211707D0 (en) *	1992-06-03	1992-07-15	Celltech Ltd	Peptidyl derivatives
US5376664A (en) *	1992-07-27	1994-12-27	The Du Pont Merck Pharmaceutical Company	Unsymmetrical mono-3-nitro bis-naphthalimides as anticancer agents
EP0671911A4 (en) *	1992-11-25	1996-08-21	Merck & Co Inc	CARBOXY-PEPTIDYL DERIVATIVES FOR USE AS ACTIVE ANTI-DEGENERATIVE AGENTS.
US5552419A (en) *	1993-01-06	1996-09-03	Ciba-Geigy Corporation	Arylsulfonamido-substituted hydroxamic acids
US5455258A (en) *	1993-01-06	1995-10-03	Ciba-Geigy Corporation	Arylsulfonamido-substituted hydroxamic acids
US5506242A (en) *	1993-01-06	1996-04-09	Ciba-Geigy Corporation	Arylsufonamido-substituted hydroxamic acids
GB9307956D0 (en) *	1993-04-17	1993-06-02	Walls Alan J	Hydroxamic acid derivatives
GB9308695D0 (en) *	1993-04-27	1993-06-09	Celltech Ltd	Peptidyl derivatives
ATE157979T1 (de) *	1993-08-05	1997-09-15	Syntex Inc	Matrix-metalloprotease inhibitoren
US6013792A (en) *	1993-08-05	2000-01-11	Syntex (U.S.A.), Inc.	Matrix metalloprotease inhibitors
UA48121C2 (uk) *	1993-11-04	2002-08-15	Сінтекс (С.Ш.А.) Інк.	Інгібітори матричних металопротеаз і фармацетична композиція на їх основі
US6037472A (en) *	1993-11-04	2000-03-14	Syntex (U.S.A.) Inc.	Matrix metalloprotease inhibitors
DK0740655T3 (da) *	1994-01-22	2000-03-27	British Biotech Pharm	Metalloproteinaseinhibitorer
US5514716A (en) *	1994-02-25	1996-05-07	Sterling Winthrop, Inc.	Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof
AU2572295A (en) *	1994-05-28	1995-12-21	British Biotech Pharmaceuticals Limited	Succinyl hydroxamic acid, n-formyl-n-hydroxy amino carboxylic acid and succinic acid amide derivatives as metalloprotease inhibitors
JPH10507158A (ja) *	1994-06-22	1998-07-14	ブリティッシュバイオテックファーマシューティカルズリミテッド	金属タンパク質分解酵素阻害剤
GB9416897D0 (en) *	1994-08-20	1994-10-12	British Biotech Pharm	Metalloproteinase inhibitors
GB9423914D0 (en) *	1994-11-26	1995-01-11	British Biotech Pharm	Polyether derivatives as metalloproteinase inhibitors
US5863949A (en) *	1995-03-08	1999-01-26	Pfizer Inc	Arylsulfonylamino hydroxamic acid derivatives
EP0821671B1 (en) *	1995-04-20	2000-12-27	Pfizer Inc.	Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors
KR980009238A (ko) *	1995-07-28	1998-04-30	우에노 도시오	설포닐아미노산 유도체
DE69624536T2 (de) *	1995-08-08	2003-06-05	Ono Pharmaceutical Co. Ltd., Osaka	Hydroxamsäurederivate verwendbar zur Hemmung von Gelatinase
PL186869B1 (pl) *	1995-11-13	2004-03-31	Hoechst Ag	Nowe heterocykliczne N-podstawione pochodne kwasów alfa-iminohydroksamowych i karboksylowych, sposób ich wytwarzania, środek farmaceutyczny i ich zastosowanie
DE19542189A1 (de) *	1995-11-13	1997-05-15	Hoechst Ag	Cyclische N-substituierte alpha-Iminohydroxamsäuren
JP2000514779A (ja) *	1995-11-17	2000-11-07	ワーナー−ランバート・コンパニー	マトリックスメタロプロティナーゼのスルホンアミド阻害剤
US5753653A (en) *	1995-12-08	1998-05-19	Agouron Pharmaceuticals, Inc.	Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
IL124559A (en) *	1995-12-08	2004-07-25	Agouron Pharma	Inhibitors of metalloproteinases, pharmaceutical preparations containing them and their use
TW453995B (en) *	1995-12-15	2001-09-11	Novartis Ag	Certain alpha-substituted arylsulfonamido acetohydroxamic acids
EP0780386B1 (en) *	1995-12-20	2002-10-02	F. Hoffmann-La Roche Ag	Matrix metalloprotease inhibitors
US6008220A (en) *	1995-12-22	1999-12-28	Warner Lambert Company	Aromatic keto-acids and their derivatives as inhibitors of matrix metalloproteinases
US5837224A (en) *	1996-01-19	1998-11-17	The Regents Of The University Of Michigan	Method of inhibiting photoaging of skin
RU2198656C2 (ru) *	1996-01-23	2003-02-20	Шионоги Энд Ко., Лтд.	Сульфированные аминокислотные производные и содержащие их ингибиторы металлопротеиназ
PL331895A1 (en) *	1996-08-23	1999-08-16	Pfizer	Arylosulphonylamino derivatives of hydroxamic acid
NZ334256A (en) *	1996-08-28	2000-11-24	Procter & Gamble	1-substituted sulphonyl-pyrrolidine derivatives useful as metalloprotease inhibitors
CN1228773A (zh) *	1996-08-28	1999-09-15	普罗克特和甘保尔公司	杂环金属蛋白酶抑制剂
US5929097A (en) *	1996-10-16	1999-07-27	American Cyanamid Company	Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
US5985900A (en) *	1997-04-01	1999-11-16	Agouron Pharmaceuticals, Inc.	Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses

1996
- 1996-12-05 IL IL12455996A patent/IL124559A/en not_active IP Right Cessation
- 1996-12-05 CN CNA2004100335232A patent/CN1542002A/zh active Pending
- 1996-12-05 SK SK738-98A patent/SK73898A3/sk unknown
- 1996-12-05 EP EP96944229A patent/EP0874830B1/en not_active Expired - Lifetime
- 1996-12-05 BR BR9611929A patent/BR9611929A/pt active Search and Examination
- 1996-12-05 AT AT00128719T patent/ATE283264T1/de not_active IP Right Cessation
- 1996-12-05 DE DE69626684T patent/DE69626684T2/de not_active Expired - Fee Related
- 1996-12-05 JP JP9521405A patent/JP2000502330A/ja not_active Ceased
- 1996-12-05 ES ES96944229T patent/ES2195034T3/es not_active Expired - Lifetime
- 1996-12-05 AP APAP/P/1998/001284A patent/AP1368A/en active
- 1996-12-05 AP APAP/P/2001/002270A patent/AP1288A/en active
- 1996-12-05 PT PT96944229T patent/PT874830E/pt unknown
- 1996-12-05 CA CA002238306A patent/CA2238306A1/en not_active Abandoned
- 1996-12-05 AT AT96944229T patent/ATE234291T1/de not_active IP Right Cessation
- 1996-12-05 DK DK96944229T patent/DK0874830T3/da active
- 1996-12-05 AU AU14091/97A patent/AU725831C/en not_active Ceased
- 1996-12-05 WO PCT/US1996/019328 patent/WO1997020824A1/en not_active Application Discontinuation
- 1996-12-05 CN CNB961995831A patent/CN1207289C/zh not_active Expired - Fee Related
- 1996-12-05 GE GEAP19964389A patent/GEP20012388B/en unknown
- 1996-12-05 NZ NZ325559A patent/NZ325559A/xx unknown
- 1996-12-05 SI SI9630588T patent/SI0874830T1/xx unknown
- 1996-12-05 EP EP00128719A patent/EP1095936B1/en not_active Expired - Lifetime
- 1996-12-05 IL IL13802796A patent/IL138027A/en not_active IP Right Cessation
- 1996-12-05 TR TR1998/00990T patent/TR199800990T2/xx unknown
- 1996-12-05 KR KR1019980704301A patent/KR19990072009A/ko not_active Application Discontinuation
- 1996-12-05 PL PL96327275A patent/PL327275A1/xx unknown
- 1996-12-05 CZ CZ19981733A patent/CZ292942B6/cs not_active IP Right Cessation
- 1996-12-05 IL IL13481696A patent/IL134816A/xx not_active IP Right Cessation
- 1996-12-05 DE DE69633947T patent/DE69633947T2/de not_active Expired - Fee Related
- 1996-12-05 HU HU9902092A patent/HUP9902092A3/hu unknown
- 1996-12-05 ES ES00128719T patent/ES2233275T3/es not_active Expired - Lifetime
- 1996-12-05 EA EA199800541A patent/EA003294B1/ru not_active IP Right Cessation
- 1996-12-05 US US09/011,971 patent/US6153757A/en not_active Expired - Fee Related
1997
- 1997-01-18 MY MYPI97000193A patent/MY117290A/en unknown
- 1997-01-22 HR HR96/019,328A patent/HRP970031A2/hr not_active Application Discontinuation
- 1997-01-23 TW TW086100726A patent/TW546293B/zh not_active IP Right Cessation
- 1997-01-29 GT GT199700015A patent/GT199700015A/es unknown
- 1997-01-29 GT GT199700015AK patent/GT199700015AA/es unknown
- 1997-02-06 SV SV1997000008A patent/SV1997000008A/es not_active Application Discontinuation
- 1997-02-12 CO CO97007169A patent/CO4790150A1/es unknown
- 1997-05-26 YU YU21597A patent/YU21597A/sr unknown
- 1997-05-27 PE PE1997000427A patent/PE69298A1/es not_active Application Discontinuation
- 1997-05-30 PA PA19978431301A patent/PA8431301A1/es unknown
- 1997-06-02 ID IDP971874A patent/ID17624A/id unknown
1998
- 1998-06-03 OA OA9800074A patent/OA10794A/en unknown
- 1998-06-04 MX MX9804457A patent/MX9804457A/es not_active IP Right Cessation
- 1998-06-05 NO NO19982590A patent/NO311360B1/no unknown
- 1998-06-05 BG BG102510A patent/BG64279B1/bg unknown
2000
- 2000-08-23 IL IL13802700A patent/IL138027A0/xx unknown
- 2000-08-23 IL IL13802800A patent/IL138028A0/xx unknown
2001
- 2001-06-11 IL IL14367401A patent/IL143674A0/xx unknown

Also Published As

Publication number	Publication date
EP1095936A1 (en)	2001-05-02
GEP20012388B (en)	2001-03-25
EA003294B1 (ru)	2003-04-24
WO1997020824A1 (en)	1997-06-12
TW546293B (en)	2003-08-11
ES2195034T3 (es)	2003-12-01
PT874830E (pt)	2003-06-30
PE69298A1 (es)	1998-11-13
IL134816A0 (en)	2001-05-20
EA199800541A1 (ru)	1998-12-24
ATE234291T1 (de)	2003-03-15
CA2238306A1 (en)	1997-06-12
AP2001002270A0 (en)	2001-09-30
CN1542002A (zh)	2004-11-03
PA8431301A1 (es)	2000-05-24
NZ325559A (en)	2000-01-28
OA10794A (en)	2001-07-05
TR199800990T2 (xx)	1998-07-21
SK73898A3 (en)	1999-01-11
IL138027A (en)	2004-08-31
DE69633947T2 (de)	2005-12-01
CO4790150A1 (es)	1999-05-31
PL327275A1 (en)	1998-12-07
BG102510A (en)	1999-08-31
MX9804457A (es)	1998-09-30
AP1288A (en)	2004-07-21
IL138027A0 (en)	2001-10-31
US6153757A (en)	2000-11-28
AP1368A (en)	2005-04-21
NO982590D0 (no)	1998-06-05
DE69633947D1 (de)	2004-12-30
BR9611929A (pt)	1999-05-18
ID17624A (id)	1998-01-15
CN1207734A (zh)	1999-02-10
EP0874830B1 (en)	2003-03-12
EP1095936B1 (en)	2004-11-24
ES2233275T3 (es)	2005-06-16
GT199700015AA (es)	1998-07-23
HRP970031A2 (en)	1998-08-31
EP0874830A1 (en)	1998-11-04
CZ173398A3 (cs)	1998-11-11
SI0874830T1 (en)	2003-08-31
NO311360B1 (no)	2001-11-19
AP9801284A0 (en)	1998-09-30
DE69626684D1 (de)	2003-04-17
KR19990072009A (ko)	1999-09-27
IL124559A0 (en)	1998-12-06
IL143674A0 (en)	2002-04-21
GT199700015A (es)	1998-07-23
IL124559A (en)	2004-07-25
NO982590L (no)	1998-08-05
YU21597A (en)	1999-11-22
MY117290A (en)	2004-06-30
ATE283264T1 (de)	2004-12-15
AU1409197A (en)	1997-06-27
DE69626684T2 (de)	2004-04-29
IL138028A0 (en)	2001-10-31
SV1997000008A (es)	1999-02-15
JP2000502330A (ja)	2000-02-29
CZ292942B6 (cs)	2004-01-14
BG64279B1 (bg)	2004-08-31
HUP9902092A3 (en)	2000-12-28
IL134816A (en)	2003-02-12
AU725831C (en)	2002-10-17
HUP9902092A2 (hu)	1999-09-28
CN1207289C (zh)	2005-06-22
AU725831B2 (en)	2000-10-19

Publication	Publication Date	Title
DK0874830T3 (da)	2003-04-22	Metalloproteinaseinhibitor, farmaceutisk præparat indeholdende denne og den farmaceutiske anvendelse samt en fremgangsmåde til fremstilling deraf
DK0811006T3 (da)	2003-08-04	Benzopyranholdige forbindelser og fremgangsmåde til deres anvendelse
DK0729956T3 (da)	2001-11-26	Benzothi9phenforbindelser, emllemprodukter, præparater og fremgangsmåder
NO20006717D0 (no)	2000-12-29	Proteaseinhibitorer
NO975411D0 (no)	1997-11-25	Tetnings- og forankringsinnretning for et brönnverktöy
DE69633645D1 (de)	2004-11-18	Vorrichtung zum Verabreichen von Medikamenten
DE69621026D1 (de)	2002-06-06	Zyklische gmp-spezifische phosphodiesteraseinhibitoren
NO964063L (no)	1997-04-01	System og fremgangsmåte for komplettering av en brönn
NO965294D0 (no)	1996-12-11	Emulsjon, kosmetisk og farmasöytisk preparat inneholdende denne samt anvendelse derav
EE9900517A (et)	2000-06-15	Tsüklooksügenaas-2 inhibiitorite kasutamise meetod südameveresoonkonna haiguste ärahoidmiseks
TR199501472A2 (tr)	1996-07-21	Matriks metaloproteaz inhibitörler.
FI973282A (fi)	1997-08-08	Trombiinin inhibiittoreita
NO974403D0 (no)	1997-09-23	Reversible proteasehemmere
DK0858464T3 (da)	2003-08-25	Thrombin-inhibitorer
DE69629142D1 (de)	2003-08-28	Verpackungs-Verfahren
DK378988A (da)	1989-01-10	Dopamin-beta-hydroxylaseinhibitorer, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende disse forbindelser
DK1003383T4 (da)	2010-01-25	Smagsforstærkende N-ethyl-p-menthan-3-carboxamidindeholdende forbindelser og fremgangsmåde til fremstilling og anvendelse deraf
EE9800044A (et)	1998-08-17	Prolüülendopeptidaasi inhibiitorid
DK0901320T3 (da)	2001-09-24	Dyreidentifikationsindretning til oral indgivelse
BR9610514A (pt)	1999-03-30	Inibidores cicloantihelmínticos
NO970481D0 (no)	1997-02-04	Emballasje samt fremgangsmåte og verktöy for fremstilling av denne
ITMI950384A0 (it)	1995-02-28	Apparecchio per aerosolterapia
KR970703937A (ko)	1997-08-09	금속단백질 분해효소 억제제(Metallproteinase inhibitors)
SE9303549D0 (sv)	1993-10-29	Förpackningssätt samt anordning härför
NO940574D0 (no)	1994-02-18	Fortilsats og for inneholdende denne